These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Acute hospital administration of amiodarone and/or lidocaine in shockable patients presenting with out-of-hospital cardiac arrest: A nationwide cohort study. Huang CH; Yu PH; Tsai MS; Chuang PY; Wang TD; Chiang CY; Chang WT; Ma MH; Tang CH; Chen WJ Int J Cardiol; 2017 Jan; 227():292-298. PubMed ID: 27843049 [TBL] [Abstract][Full Text] [Related]
6. Amiodarone Versus Lidocaine for Pediatric Cardiac Arrest Due to Ventricular Arrhythmias: A Systematic Review. McBride ME; Marino BS; Webster G; Lopez-Herce J; Ziegler CP; De Caen AR; Atkins DL Pediatr Crit Care Med; 2017 Feb; 18(2):183-189. PubMed ID: 28009655 [TBL] [Abstract][Full Text] [Related]
7. 2018 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Duff JP; Topjian A; Berg MD; Chan M; Haskell SE; Joyner BL; Lasa JJ; Ley SJ; Raymond TT; Sutton RM; Hazinski MF; Atkins DL Circulation; 2018 Dec; 138(23):e731-e739. PubMed ID: 30571264 [TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest. Wagner D; Kronick SL; Nawer H; Cranford JA; Bradley SM; Neumar RW Chest; 2023 May; 163(5):1109-1119. PubMed ID: 36332663 [TBL] [Abstract][Full Text] [Related]
9. Procainamide for shockable rhythm cardiac arrest in the Resuscitation Outcome Consortium. Huebinger R; Harvin JA; Chan HK; Idris A; Cooper B; Giordano J; Wang HE Am J Emerg Med; 2022 May; 55():143-146. PubMed ID: 35325787 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of lidocaine and amiodarone for out-of-hospital cardiac arrest patients with shockable rhythms: a retrospective observational study from a multicenter registry. Kishihara Y; Kashiura M; Amagasa S; Fukushima F; Yasuda H; Moriya T BMC Cardiovasc Disord; 2022 Nov; 22(1):466. PubMed ID: 36335307 [TBL] [Abstract][Full Text] [Related]
11. Outcomes associated with amiodarone and lidocaine for the treatment of adult in-hospital cardiac arrest with shock-refractory pulseless ventricular tachyarrhythmia. Wang CH; Chang WT; Huang CH; Tsai MS; Yu PH; Wu YW; Liu YB; Chen WJ J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):327-334. PubMed ID: 31255419 [TBL] [Abstract][Full Text] [Related]
12. Amiodarone Compared with Lidocaine for Out-Of-Hospital Cardiac Arrest with Refractory Ventricular Fibrillation on Hospital Arrival: a Nationwide Database Study. Tagami T; Matsui H; Tanaka C; Kaneko J; Kuno M; Ishinokami S; Unemoto K; Fushimi K; Yasunaga H Cardiovasc Drugs Ther; 2016 Oct; 30(5):485-491. PubMed ID: 27618826 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of antiarrhythmic drugs for shockable cardiac arrest: A systematic review. Ali MU; Fitzpatrick-Lewis D; Kenny M; Raina P; Atkins DL; Soar J; Nolan J; Ristagno G; Sherifali D Resuscitation; 2018 Nov; 132():63-72. PubMed ID: 30179691 [TBL] [Abstract][Full Text] [Related]
14. First documented rhythm and clinical outcome in children who undergo extracorporeal cardiopulmonary resuscitation for in-hospital cardiac arrest: A report from the american heart association get with the guidelines® - resuscitation registry (GWTG-R). Perry T; Bakar A; Bembea MM; Fishbein J; Sweberg T; Resuscitation; 2023 Dec; 193():110040. PubMed ID: 37949164 [TBL] [Abstract][Full Text] [Related]
15. Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Shock-Refractory Cardiac Arrest. Daya MR; Leroux BG; Dorian P; Rea TD; Newgard CD; Morrison LJ; Lupton JR; Menegazzi JJ; Ornato JP; Sopko G; Christenson J; Idris A; Mody P; Vilke GM; Herdeman C; Barbic D; Kudenchuk PJ; Circulation; 2020 Jan; 141(3):188-198. PubMed ID: 31941354 [TBL] [Abstract][Full Text] [Related]
16. Resuscitation Outcomes Consortium-Amiodarone, Lidocaine or Placebo Study (ROC-ALPS): Rationale and methodology behind an out-of-hospital cardiac arrest antiarrhythmic drug trial. Kudenchuk PJ; Brown SP; Daya M; Morrison LJ; Grunau BE; Rea T; Aufderheide T; Powell J; Leroux B; Vaillancourt C; Larsen J; Wittwer L; Colella MR; Stephens SW; Gamber M; Egan D; Dorian P; Am Heart J; 2014 May; 167(5):653-9.e4. PubMed ID: 24766974 [TBL] [Abstract][Full Text] [Related]
17. Effect of Time to Treatment With Antiarrhythmic Drugs on Return of Spontaneous Circulation in Shock-Refractory Out-of-Hospital Cardiac Arrest. Rahimi M; Dorian P; Cheskes S; Lebovic G; Lin S J Am Heart Assoc; 2022 Mar; 11(6):e023958. PubMed ID: 35243875 [TBL] [Abstract][Full Text] [Related]
18. Drugs in cardiac arrest: the rise and fall of antiarrhythmics. Karlis G; Afantenou S Acta Cardiol; 2018 Aug; 73(4):325-327. PubMed ID: 29025372 [TBL] [Abstract][Full Text] [Related]
19. Survival by time-to-administration of amiodarone, lidocaine, or placebo in shock-refractory out-of-hospital cardiac arrest. Lupton JR; Neth MR; Sahni R; Jui J; Wittwer L; Newgard CD; Daya MR Acad Emerg Med; 2023 Sep; 30(9):906-917. PubMed ID: 36869657 [TBL] [Abstract][Full Text] [Related]
20. Increasing amiodarone use in cardiopulmonary resuscitation: an analysis of the National Registry of Cardiopulmonary Resuscitation. October TW; Schleien CL; Berg RA; Nadkarni VM; Morris MC; Crit Care Med; 2008 Jan; 36(1):126-30. PubMed ID: 18090352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]